Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application.

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Oncology

Background:

• Sonodynamic therapy (SDT) leverages ultrasound (US) to activate sonosensitizers, enhancing cancer treatment efficacy.
• Acoustically responsive nanodrugs offer novel approaches for targeted drug delivery and cancer therapy.
• SDT shows promise for noninvasive, site-directed elimination of solid tumors.

Purpose of the Study:

• To review the therapeutic applications of sono-responsive drug delivery systems in cancer treatment.
• To examine the mechanisms of SDT, including radical generation and US-assisted sonoporation.
• To explore the integration of SDT with other therapies for enhanced synergistic effects.

Main Methods:

• Review of current literature on SDT and nanomedicine for cancer therapy.
• Analysis of mechanisms underlying SDT, including sonosensitizer activation and drug delivery.
• Discussion of multimodal synergistic therapies such as sonophototherapy, sonoimmunotherapy, and sonochemotherapy.

Main Results:

• SDT enhances the cytotoxic activity of sonosensitizers through ultrasound activation.
• Mechanisms include radical generation, cell membrane disruption, and enhanced drug uptake via sonoporation.
• Multimodal therapies combining SDT with other modalities show improved efficacy for complex tumors.

Conclusions:

• SDT-based nanomedicines represent a promising frontier in precision cancer treatment.
• Audible sound waves offer novel therapeutic avenues by influencing cellular processes.
• Further research into SDT nanomedicines is crucial for advancing noninvasive cancer therapies.